
|Slideshows|August 20, 2018
Cardiovascular Risk in T2DM Linked to Inflammatory Markers
Author(s)Gregory M. Weiss, MD
Patients with T2DM and proven cardiovascular disease have elevated markers of inflammation and endothelial stress, according to a new study.
Advertisement
Reference: Shore AC, Colhoun HM, Natali A, et al. Use of vascular assessments and novel biomarkers to predict cardiovascular events in type 2 diabetes: The SUMMIT VIP study. Diabetes Care. 2018.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5


























































